[go: up one dir, main page]

WO2013013019A3 - Polypeptides lysosomaux, procédés de préparation et d'utilisation - Google Patents

Polypeptides lysosomaux, procédés de préparation et d'utilisation Download PDF

Info

Publication number
WO2013013019A3
WO2013013019A3 PCT/US2012/047356 US2012047356W WO2013013019A3 WO 2013013019 A3 WO2013013019 A3 WO 2013013019A3 US 2012047356 W US2012047356 W US 2012047356W WO 2013013019 A3 WO2013013019 A3 WO 2013013019A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
lysosomal proteins
macrophages
making
target cells
Prior art date
Application number
PCT/US2012/047356
Other languages
English (en)
Other versions
WO2013013019A2 (fr
Inventor
Anthony Rossomando
Brian Bettencourt
Original Assignee
Alnylam Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alnylam Pharmaceuticals, Inc. filed Critical Alnylam Pharmaceuticals, Inc.
Publication of WO2013013019A2 publication Critical patent/WO2013013019A2/fr
Publication of WO2013013019A3 publication Critical patent/WO2013013019A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins
    • C07K14/8125Alpha-1-antitrypsin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2465Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase (3.2.1.22)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y204/00Glycosyltransferases (2.4)
    • C12Y204/01Hexosyltransferases (2.4.1)
    • C12Y204/01101Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase (2.4.1.101)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/11Antisense
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/14Type of nucleic acid interfering nucleic acids [NA]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed
    • C12N2310/531Stem-loop; Hairpin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne de manière générale des compositions et des procédés de production de protéines lysosomales qui présentent une structure glycane modifiée, de telle sorte que la protéine peut être délivrée efficacement dans les lysosomes de cellules cibles (comme des macrophages). Les protéines lysosomales sont produites en modifiant les voies de glycosylation dans une cellule hôte en utilisant une molécule effectrice d'ARN, comme un ARNsi. Les protéines lysosomales à glycane modifié produites au moyen des procédés décrits ici présentent des propriétés améliorées, notamment, par exemple, une absorption spécifique accrue par les cellules cibles (comme les macrophages).
PCT/US2012/047356 2011-07-21 2012-07-19 Polypeptides lysosomaux, procédés de préparation et d'utilisation WO2013013019A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201161510437P 2011-07-21 2011-07-21
US61/510,437 2011-07-21
US201161533002P 2011-09-09 2011-09-09
US61/533,002 2011-09-09
US201261617322P 2012-03-29 2012-03-29
US61/617,322 2012-03-29

Publications (2)

Publication Number Publication Date
WO2013013019A2 WO2013013019A2 (fr) 2013-01-24
WO2013013019A3 true WO2013013019A3 (fr) 2013-05-10

Family

ID=47558722

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/047356 WO2013013019A2 (fr) 2011-07-21 2012-07-19 Polypeptides lysosomaux, procédés de préparation et d'utilisation

Country Status (1)

Country Link
WO (1) WO2013013019A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019535839A (ja) 2016-11-29 2019-12-12 ピュアテック ヘルス エルエルシー 治療剤の送達のためのエクソソーム
JP2022530824A (ja) * 2019-04-30 2022-07-01 ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア ポンペ病の治療のために有用な組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100186099A1 (en) * 2003-10-28 2010-07-22 Fraser Malcom J Production of Human Glycosylated Proteins in Silk Worm
US20110067146A1 (en) * 2007-04-17 2011-03-17 Plant Research International B.V. Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100186099A1 (en) * 2003-10-28 2010-07-22 Fraser Malcom J Production of Human Glycosylated Proteins in Silk Worm
US20110067146A1 (en) * 2007-04-17 2011-03-17 Plant Research International B.V. Mammalian-type glycosylation in plants by expression of non-mammalian glycosyltransferases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SCHENK ET AL.: "MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If", J. CLIN. INVEST., vol. 108, 2001, pages 1687 - 1695 *

Also Published As

Publication number Publication date
WO2013013019A2 (fr) 2013-01-24

Similar Documents

Publication Publication Date Title
WO2013013017A3 (fr) Compositions et procédés pour modifier la glycosylation de substances thérapeutiques pour les troubles du stockage lysosomal
WO2013013013A3 (fr) Compositions et procédés de production de glycoprotéines modifiées
WO2012103300A3 (fr) Polypeptides ayant une activité cellobiohydrolase et polynucléotides codant pour ceux-ci
EA201200516A1 (ru) Способ продуцирования молекул, содержащих специализированные гликановые структуры
WO2013019827A3 (fr) Polypeptides ayant une activité xylanase et polynucléotides codant pour ceux-ci
WO2011035027A3 (fr) Polypeptides ayant une activité cellulolytique améliorée et polynucléotides codant pour ceux-ci
EP2735611A3 (fr) Polypeptides dotés d'activité d'amélioration cellulolytique et polynucléotides les codant
WO2012153193A3 (fr) Conjugués protéine-principe actif et leur procédé de préparation
MX351565B (es) Colageno 7 y metodos relacionados.
WO2010120514A3 (fr) Protéines liant des antigènes comprenant des échafaudages protéiniques internes recombinants
MX351916B (es) Polipeptidos que tienen actividad de lisozima y polinucleotdos que los codifican.
EA201300074A1 (ru) Способ получения представляющего интерес соединения
WO2013057141A3 (fr) Variants d'alpha-amylase et polynucléotides les codant
WO2014097113A3 (fr) Production de protéines thérapeutiques dans des cellules de mammifère génétiquement modifiées
EP4253534A3 (fr) Variants d'alpha-amylase et polynucléotides les codant
WO2013019780A3 (fr) Polypeptides ayant une activité endoglucanase et polynucléotides codant pour ceux-ci
IN2015DN03206A (fr)
WO2012136898A3 (fr) Nouvelles cutinases, leur préparation et leurs utilisations
WO2012175708A3 (fr) Polypeptides ayant une activité de protéase et polynucléotides les codant
WO2010088463A3 (fr) Polypeptides à activité d'expansine et polynucléotides codant pour lesdits polypeptides
MX2012014138A (es) Metodo para produccion mejorada de proteinas en hongo filamentoso.
MX2014001594A (es) Polipeptidos que tienen actividad de celulasa y polinucleotidos que los codifican.
WO2011151512A3 (fr) Procédé de production de protéines à partir de champignons filamenteux
WO2008033556A3 (fr) Traitement de protéines sous haute pression permettant de réduire leur immunogénicité
MX2012001060A (es) Carbohidrato-oxidasas.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12814774

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12814774

Country of ref document: EP

Kind code of ref document: A2